Elite Capital
8
36M
4
0.35
2
1
- Areas of investment
Summary
Elite Capital is the famous VC, which was founded in 1998. The venture was found in Asia in China. The leading representative office of defined VC is situated in the Beijing.
The important activity for fund was in 2018. Considering the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 investment rounds annually. Deals in the range of 50 - 100 millions dollars are the general things for fund.
The typical case for the fund is to invest in rounds with 6-7 participants. Despite the Elite Capital, startups are often financed by CrestValue. The meaningful sponsors for the fund in investment in the same round are Yingke Capital, Sangel Capital, SDIC Venture Capital.
The fund has exact preference in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Health Care. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline KBP Biosciences, Haihe Biopharma, Kuaile Zhihui
Investments analytics
Analytics
- Total investments
- 8
- Lead investments
- 2
- Exits
- 1
- Rounds per year
- 0.35
- Investments by industry
- Medical (4)
- Health Care (2)
- Biotechnology (1)
- Test and Measurement (1)
- Retail (1) Show 4 more
- Investments by region
-
- China (4)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 1M
- Group Appearance index
- 0.14
- Avg. company exit year
- 6
- Avg. multiplicator
- 0.79
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Crabyter | 08 Sep 2015 | Information Technology, Information Services, Medical | Early Stage Venture | 3M | Shanghai, Putuo, China |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.